{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T12:12:56Z","timestamp":1789992776066,"version":"4.0.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:00:00Z","timestamp":1789948800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:00:00Z","timestamp":1789948800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"AM-Pharma BV"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Intensive Care Med"],"DOI":"10.1007\/s00134-026-08596-y","type":"journal-article","created":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T11:40:03Z","timestamp":1789990803000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A multicenter randomized, double-blinded placebo-controlled phase 2 trial to evaluate safety and efficacy of ilofotase alfa in patients at risk for kidney injury following open heart surgery"],"prefix":"10.1007","clinical-trial-number":[{"clinical-trial-number":"nct06168799","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5785-9172","authenticated-orcid":false,"given":"Louis","family":"Mourisse","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marlies","family":"Ostermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Thiessen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Dumoulin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander P. J.","family":"Vlaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Hoste","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selim","family":"Mosbahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Zarbock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Boehm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Rosenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Thielmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Dubois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonah","family":"Powell-Tuck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamran","family":"Baig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wencke","family":"Renette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid","family":"Meex","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margreet","family":"Klop-Rhiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krijna","family":"Opschoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wim","family":"Vandenberghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Siepe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Strauss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Wirth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Winkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liesbeth","family":"Hof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maarten","family":"Kraan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliane","family":"Bernholz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Pickkers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the study team","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nienke","family":"Geelink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisy","family":"Vermeiren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolien","family":"Van Hecke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anouska","family":"De Smeytere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lesley","family":"Decoster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrin","family":"Sch\u00fctzenmeister","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hendrik","family":"Booke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moritz","family":"Mertes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Bernard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valbona","family":"Mirakaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Hermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Thielmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Ristau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,21]]},"reference":[{"key":"8596_CR1","doi-asserted-by":"publisher","first-page":"c179","DOI":"10.1159\/000339789","volume":"120","author":"A Khwaja","year":"2012","unstructured":"Khwaja A (2012) KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract 120:c179\u2013c184. https:\/\/doi.org\/10.1159\/000339789","journal-title":"Nephron Clin Pract"},{"key":"8596_CR2","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.jtcvs.2019.11.137","volume":"162","author":"P Priyanka","year":"2021","unstructured":"Priyanka P, Zarbock A, Izawa J, Gleason TG, Renfurm RW, Kellum JA (2021) The impact of acute kidney injury by serum creatinine or urine output criteria on major adverse kidney events in cardiac surgery patients. J Thorac Cardiovasc Surg 162:143-151.e147. https:\/\/doi.org\/10.1016\/j.jtcvs.2019.11.137","journal-title":"J Thorac Cardiovasc Surg"},{"key":"8596_CR3","doi-asserted-by":"publisher","first-page":"19","DOI":"10.2215\/CJN.00240605","volume":"1","author":"MH Rosner","year":"2006","unstructured":"Rosner MH, Okusa MD (2006) Acute kidney injury associated with cardiac surgery. Clin J Am Soc Nephrol 1:19\u201332. https:\/\/doi.org\/10.2215\/CJN.00240605","journal-title":"Clin J Am Soc Nephrol"},{"key":"8596_CR4","doi-asserted-by":"publisher","first-page":"15672","DOI":"10.1038\/s41598-021-94946-3","volume":"11","author":"A Abebe","year":"2021","unstructured":"Abebe A, Kumela K, Belay M, Kebede B, Wobie Y (2021) Mortality and predictors of acute kidney injury in adults: a hospital-based prospective observational study. Sci Rep 11:15672. https:\/\/doi.org\/10.1038\/s41598-021-94946-3","journal-title":"Sci Rep"},{"key":"8596_CR5","doi-asserted-by":"publisher","first-page":"9689","DOI":"10.3390\/ijms21249689","volume":"21","author":"A Casas","year":"2020","unstructured":"Casas A, Mall\u00e9n A, Blasco-Lucas A, Sbraga F, Guiteras J, Bola\u00f1os N, Casta\u00f1o E, Torras J, Cruzado JM, Navarro E, Hueso M (2020) Chronic kidney disease-associated inflammation increases the risks of acute kidney injury and mortality after cardiac surgery. Int J Mol Sci 21:9689. https:\/\/doi.org\/10.3390\/ijms21249689","journal-title":"Int J Mol Sci"},{"key":"8596_CR6","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.2215\/cjn.11141113","volume":"9","author":"JR Prowle","year":"2014","unstructured":"Prowle JR, Kolic I, Purdell-Lewis J, Taylor R, Pearse RM, Kirwan CJ (2014) Serum creatinine changes associated with critical illness and detection of persistent renal dysfunction after AKI. Clin J Am Soc Nephrol 9:1015\u20131023. https:\/\/doi.org\/10.2215\/cjn.11141113","journal-title":"Clin J Am Soc Nephrol"},{"key":"8596_CR7","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.3390\/jcm10081556","volume":"10","author":"SH Choe","year":"2021","unstructured":"Choe SH, Cho H, Bae J, Ji SH, Yoon HK, Lee HJ, Lee JH, Kim JT, Kim WH (2021) Severity and duration of acute kidney injury and chronic kidney disease after cardiac surgery. J Clin Med 10:1556. https:\/\/doi.org\/10.3390\/jcm10081556","journal-title":"J Clin Med"},{"key":"8596_CR8","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1681\/asn.2004040331","volume":"16","author":"CV Thakar","year":"2005","unstructured":"Thakar CV, Arrigain S, Worley S, Yared JP, Paganini EP (2005) A clinical score to predict acute renal failure after cardiac surgery. J Am Soc Nephrol 16:162\u2013168. https:\/\/doi.org\/10.1681\/asn.2004040331","journal-title":"J Am Soc Nephrol"},{"key":"8596_CR9","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1186\/s13054-016-1352-z","volume":"20","author":"JB O\u2019Neal","year":"2016","unstructured":"O\u2019Neal JB, Shaw AD, Billings FT (2016) Acute kidney injury following cardiac surgery: current understanding and future directions. Crit Care 20:187. https:\/\/doi.org\/10.1186\/s13054-016-1352-z","journal-title":"Crit Care"},{"key":"8596_CR10","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s12882-018-0946-x","volume":"19","author":"SH Howitt","year":"2018","unstructured":"Howitt SH, Grant SW, Caiado C, Carlson E, Kwon D, Dimarakis I, Malagon I, McCollum C (2018) The KDIGO acute kidney injury guidelines for cardiac surgery patients in critical care: a validation study. BMC Nephrol 19:149. https:\/\/doi.org\/10.1186\/s12882-018-0946-x","journal-title":"BMC Nephrol"},{"key":"8596_CR11","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1161\/circulationaha.114.010622","volume":"130","author":"L Ryd\u00e9n","year":"2014","unstructured":"Ryd\u00e9n L, Sartipy U, Evans M, Holzmann MJ (2014) Acute kidney injury after coronary artery bypass grafting and long-term risk of end-stage renal disease. Circulation 130:2005\u20132011. https:\/\/doi.org\/10.1161\/circulationaha.114.010622","journal-title":"Circulation"},{"key":"8596_CR12","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.ahj.2014.12.019","volume":"169","author":"SS Han","year":"2015","unstructured":"Han SS, Shin N, Baek SH, Ahn SY, Kim DK, Kim S, Chin HJ, Chae D-W, Na KY (2015) Effects of acute kidney injury and chronic kidney disease on long-term mortality after coronary artery bypass grafting. Am Heart J 169:419\u2013425. https:\/\/doi.org\/10.1016\/j.ahj.2014.12.019","journal-title":"Am Heart J"},{"key":"8596_CR13","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/nrneph.2017.2","volume":"13","author":"LS Chawla","year":"2017","unstructured":"Chawla LS, Bellomo R, Bihorac A, Goldstein SL, Siew ED, Bagshaw SM, Bittleman D, Cruz D, Endre Z, Fitzgerald RL (2017) Acute kidney disease and renal recovery: consensus report of the Acute Disease Quality Initiative (ADQI) 16 Workgroup. Nat Rev Nephrol 13:241\u2013257. https:\/\/doi.org\/10.1038\/nrneph.2017.2","journal-title":"Nat Rev Nephrol"},{"key":"8596_CR14","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1164\/rccm.201311-2097oc","volume":"189","author":"A Linder","year":"2014","unstructured":"Linder A, Fjell C, Levin A, Walley KR, Russell JA, Boyd JH (2014) Small acute increases in serum creatinine are associated with decreased long-term survival in the critically ill. Am J Respir Crit Care Med 189:1075\u20131081. https:\/\/doi.org\/10.1164\/rccm.201311-2097oc","journal-title":"Am J Respir Crit Care Med"},{"key":"8596_CR15","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1097\/01.asn.0000130340.93930.dd","volume":"15","author":"A Lassnigg","year":"2004","unstructured":"Lassnigg A, Schmidlin D, Mouhieddine M, Bachmann LM, Druml W, Bauer P, Hiesmayr M (2004) Minimal changes of serum creatinine predict prognosis in patients after cardiothoracic surgery: a prospective cohort study. J Am Soc Nephrol 15:1597\u20131605. https:\/\/doi.org\/10.1097\/01.asn.0000130340.93930.dd","journal-title":"J Am Soc Nephrol"},{"key":"8596_CR16","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/j.ahj.2008.06.043","volume":"156","author":"PH Gibson","year":"2008","unstructured":"Gibson PH, Croal BL, Cuthbertson BH, Chiwara M, Scott AE, Buchan KG, El-Shafei H, Gibson G, Jeffrey RR, Hillis GS (2008) The relationship between renal function and outcome from heart valve surgery. Am Heart J 156:893\u2013899. https:\/\/doi.org\/10.1016\/j.ahj.2008.06.043","journal-title":"Am Heart J"},{"key":"8596_CR17","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1161\/circulationaha.105.591990","volume":"113","author":"GS Hillis","year":"2006","unstructured":"Hillis GS, Croal BL, Buchan KG, El-Shafei H, Gibson G, Jeffrey RR, Millar CG, Prescott GJ, Cuthbertson BH (2006) Renal function and outcome from coronary artery bypass grafting: impact on mortality after a 2.3-year follow-up. Circulation 113:1056\u20131062. https:\/\/doi.org\/10.1161\/circulationaha.105.591990","journal-title":"Circulation"},{"key":"8596_CR18","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1038\/sj.ki.5002419","volume":"72","author":"H Palomba","year":"2007","unstructured":"Palomba H, De Castro I, Neto A, Lage S, Yu L (2007) Acute kidney injury prediction following elective cardiac surgery: AKICS score. Kidney Int 72:624\u2013631. https:\/\/doi.org\/10.1038\/sj.ki.5002419","journal-title":"Kidney Int"},{"key":"8596_CR19","doi-asserted-by":"publisher","unstructured":"Strau\u00df C, Albert F, Bormann E, Engelman DT, Bellomo R, Zarbock A, (2025) Risk factors, outcomes, and early prediction of cardiac surgery-associated acute kidney injury: a post hoc subgroup analysis of the Epidemiology of Surgery Associated Acute Kidney Injury study. British Journal of Anaesthesia. https:\/\/doi.org\/10.1016\/j.bja.2025.08.043","DOI":"10.1016\/j.bja.2025.08.043"},{"key":"8596_CR20","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1053\/j.jvca.2011.07.007","volume":"26","author":"AB Kumar","year":"2012","unstructured":"Kumar AB, Suneja M, Bayman EO, Weide GD, Tarasi M (2012) Association between postoperative acute kidney injury and duration of cardiopulmonary bypass: a meta-analysis. J Cardiothorac Vasc Anesth 26:64\u201369. https:\/\/doi.org\/10.1053\/j.jvca.2011.07.007","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"8596_CR21","doi-asserted-by":"publisher","first-page":"22","DOI":"10.4103\/0971-9784.197823","volume":"20","author":"HM Karim","year":"2017","unstructured":"Karim HM, Yunus M, Saikia MK, Kalita JP, Mandal M (2017) Incidence and progression of cardiac surgery-associated acute kidney injury and its relationship with bypass and cross clamp time. Ann Card Anaesth 20:22\u201327. https:\/\/doi.org\/10.4103\/0971-9784.197823","journal-title":"Ann Card Anaesth"},{"key":"8596_CR22","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1038\/nrneph.2017.119","volume":"13","author":"Y Wang","year":"2017","unstructured":"Wang Y, Bellomo R (2017) Cardiac surgery-associated acute kidney injury: risk factors, pathophysiology and treatment. Nat Rev Nephrol 13:697\u2013711. https:\/\/doi.org\/10.1038\/nrneph.2017.119","journal-title":"Nat Rev Nephrol"},{"key":"8596_CR23","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1097\/aco.0000000000000412","volume":"30","author":"DY Fuhrman","year":"2017","unstructured":"Fuhrman DY, Kellum JA (2017) Epidemiology and pathophysiology of cardiac surgery-associated acute kidney injury. Curr Opin Anesthesiol 30:60\u201365. https:\/\/doi.org\/10.1097\/aco.0000000000000412","journal-title":"Curr Opin Anesthesiol"},{"key":"8596_CR24","doi-asserted-by":"publisher","first-page":"909","DOI":"10.34067\/kid.0000000000000466","volume":"5","author":"FG Scurt","year":"2024","unstructured":"Scurt FG, Bose K, Mertens PR, Chatzikyrkou C, Herzog C (2024) Cardiac surgery-associated acute kidney injury. Kidney360 5:909\u2013926. https:\/\/doi.org\/10.34067\/kid.0000000000000466","journal-title":"Kidney360"},{"key":"8596_CR25","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/cc11454","volume":"17","author":"JA Kellum","year":"2013","unstructured":"Kellum JA, Lameire N (2013) Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1). Crit Care 17:204. https:\/\/doi.org\/10.1186\/cc11454","journal-title":"Crit Care"},{"key":"8596_CR26","doi-asserted-by":"publisher","first-page":"e008834","DOI":"10.1161\/jaha.118.008834","volume":"7","author":"MK Nadim","year":"2018","unstructured":"Nadim MK, Forni LG, Bihorac A, Hobson C, Koyner JL, Shaw A, Arnaoutakis GJ, Ding X, Engelman DT, Gasparovic H, Gasparovic V, Herzog CA, Kashani K, Katz N, Liu KD, Mehta RL, Ostermann M, Pannu N, Pickkers P, Price S, Ricci Z, Rich JB, Sajja LR, Weaver FA, Zarbock A, Ronco C, Kellum JA (2018) Cardiac and Vascular Surgery-Associated Acute Kidney Injury: The 20th International Consensus Conference of the ADQI (Acute Disease Quality Initiative) Group. J Am Heart Assoc 7:e008834. https:\/\/doi.org\/10.1161\/jaha.118.008834","journal-title":"J Am Heart Assoc"},{"key":"8596_CR27","doi-asserted-by":"publisher","first-page":"155182","DOI":"10.1016\/j.cyto.2020.155182","volume":"133","author":"M Nguyen","year":"2020","unstructured":"Nguyen M, Tavernier A, Gautier T, Aho S, Morgant MC, Bouhemad B, Guinot P-G, Grober J (2020) Glucagon-like peptide-1 is associated with poor clinical outcome, lipopolysaccharide translocation and inflammation in patients undergoing cardiac surgery with cardiopulmonary bypass. Cytokine 133:155182. https:\/\/doi.org\/10.1016\/j.cyto.2020.155182","journal-title":"Cytokine"},{"key":"8596_CR28","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1097\/00024382-200116001-00009","volume":"16","author":"M Rothenburger","year":"2001","unstructured":"Rothenburger M, Soeparwata R, Deng MC, Schmid C, Berendes E, Tjan TDT, Wilhelm MJ, Erren M, B\u00f6cker D, Scheld HH (2001) Prediction of clinical outcome after cardiac surgery: the role of cytokines, endotoxin, and anti-endotoxin core antibodies. Shock 16:44\u201350. https:\/\/doi.org\/10.1097\/00024382-200116001-00009","journal-title":"Shock"},{"key":"8596_CR29","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1213\/ane.0000000000005458","volume":"133","author":"A Zarbock","year":"2021","unstructured":"Zarbock A, K\u00fcllmar M, Ostermann M, Lucchese G, Baig K, Cennamo A, Rajani R, McCorkell S, Arndt C, Wulf H, Irqsusi M, Monaco F, Di Prima AL, Garc\u00eda Alvarez M, Italiano S, Miralles Bagan J, Kunst G, Nair S, L\u2019Acqua C, Hoste E, Vandenberghe W, Honore PM, Kellum JA, Forni LG, Grieshaber P, Massoth C, Weiss R, Gerss J, Wempe C, Meersch M (2021) Prevention of cardiac surgery-associated acute kidney injury by implementing the KDIGO guidelines in high-risk patients identified by biomarkers: the PrevAKI-multicenter randomized controlled trial. Anesth Analg 133:292\u2013302. https:\/\/doi.org\/10.1213\/ane.0000000000005458","journal-title":"Anesth Analg"},{"key":"8596_CR30","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1007\/s00134-016-4670-3","volume":"43","author":"M Meersch","year":"2017","unstructured":"Meersch M, Schmidt C, Hoffmeier A, Van Aken H, Wempe C, Gerss J, Zarbock A (2017) Prevention of cardiac surgery-associated AKI by implementing the KDIGO guidelines in high risk patients identified by biomarkers: the PrevAKI randomized controlled trial. Intensive Care Med 43:1551\u20131561. https:\/\/doi.org\/10.1007\/s00134-016-4670-3","journal-title":"Intensive Care Med"},{"key":"8596_CR31","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1681\/asn.2015030309","volume":"27","author":"DP Basile","year":"2016","unstructured":"Basile DP, Bonventre JV, Mehta R, Nangaku M, Unwin R, Rosner MH, Kellum JA, Ronco C (2016) Progression after AKI: understanding maladaptive repair processes to predict and identify therapeutic treatments. J Am Soc Nephrol 27:687\u2013697. https:\/\/doi.org\/10.1681\/asn.2015030309","journal-title":"J Am Soc Nephrol"},{"key":"8596_CR32","doi-asserted-by":"publisher","first-page":"4932","DOI":"10.1111\/bph.13261","volume":"172","author":"E Peters","year":"2015","unstructured":"Peters E, Geraci S, Heemskerk S, Wilmer MJ, Bilos A, Kraenzlin B, Gretz N, Pickkers P, Masereeuw R (2015) Alkaline phosphatase protects against renal inflammation through dephosphorylation of lipopolysaccharide and adenosine triphosphate. Br J Pharmacol 172:4932\u20134945. https:\/\/doi.org\/10.1111\/bph.13261","journal-title":"Br J Pharmacol"},{"key":"8596_CR33","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1007\/s40262-016-0399-y","volume":"55","author":"E Peters","year":"2016","unstructured":"Peters E, Heuberger J, Tiessen R, van Elsas A, Masereeuw R, Arend J, Stevens J, Pickkers P (2016) Pharmacokinetic modeling and dose selection in a randomized, double-blind, placebo-controlled trial of a human recombinant alkaline phosphatase in healthy volunteers. Clin Pharmacokinet 55:1227\u20131237. https:\/\/doi.org\/10.1007\/s40262-016-0399-y","journal-title":"Clin Pharmacokinet"},{"key":"8596_CR34","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1159\/000363256","volume":"127","author":"E Peters","year":"2014","unstructured":"Peters E, Masereeuw R, Pickkers P (2014) The potential of alkaline phosphatase as a treatment for sepsis-associated acute kidney injury. Nephron Clin Pract 127:144\u2013148. https:\/\/doi.org\/10.1159\/000363256","journal-title":"Nephron Clin Pract"},{"key":"8596_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.931293","volume":"9","author":"DL Rosin","year":"2022","unstructured":"Rosin DL, Hall JP, Zheng S, Huang L, Campos-Bilderback S, Sandoval R, Bree A, Beaumont K, Miller E, Larsen J, Hariri G, Kaila N, Encarnacion IM, Gale JD, van Elsas A, Molitoris BA, Okusa MD (2022) Human recombinant alkaline phosphatase (Ilofotase Alfa) Protects against kidney ischemia-reperfusion injury in mice and rats through adenosine receptors. Front Med (Lausanne) 9:931293. https:\/\/doi.org\/10.3389\/fmed.2022.931293","journal-title":"Front Med (Lausanne)"},{"key":"8596_CR36","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.ejphar.2016.12.034","volume":"796","author":"E Peters","year":"2017","unstructured":"Peters E, Schirris T, van Asbeck AH, Gerretsen J, Eymael J, Ashikov A, Adjobo-Hermans MJ, Russel F, Pickkers P, Masereeuw R (2017) Effects of a human recombinant alkaline phosphatase during impaired mitochondrial function in human renal proximal tubule epithelial cells. Eur J Pharmacol 796:149\u2013157. https:\/\/doi.org\/10.1016\/j.ejphar.2016.12.034","journal-title":"Eur J Pharmacol"},{"key":"8596_CR37","doi-asserted-by":"publisher","first-page":"14175","DOI":"10.1038\/s41598-019-50481-w","volume":"9","author":"JA Davidson","year":"2019","unstructured":"Davidson JA, Khailova L, Treece A, Robison J, Soranno DE, Jaggers J, Ing RJ, Lawson S, Lujan SO (2019) Alkaline phosphatase treatment of acute kidney injury in an infant piglet model of cardiopulmonary bypass with deep hypothermic circulatory arrest. Sci Rep 9:14175. https:\/\/doi.org\/10.1038\/s41598-019-50481-w","journal-title":"Sci Rep"},{"key":"8596_CR38","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1001\/jama.2018.14283","volume":"320","author":"P Pickkers","year":"2018","unstructured":"Pickkers P, Mehta RL, Murray PT, Joannidis M, Molitoris BA, Kellum JA, Bachler M, Hoste EAJ, Hoiting O, Krell K, Ostermann M, Rozendaal W, Valkonen M, Brealey D, Beishuizen A, Meziani F, Murugan R, de Geus H, Payen D, van den Berg E, Arend J (2018) Effect of human recombinant alkaline phosphatase on 7-day creatinine clearance in patients with sepsis-associated acute kidney injury: a randomized clinical trial. JAMA 320:1998\u20132009. https:\/\/doi.org\/10.1001\/jama.2018.14283","journal-title":"JAMA"},{"key":"8596_CR39","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1007\/s00134-023-07271-w","volume":"50","author":"P Pickkers","year":"2024","unstructured":"Pickkers P, Angus DC, Bass K, Bellomo R, van den Berg E, Bernholz J, Bestle MH, Doi K, Doig CJ, Ferrer R, Francois B, Gammelager H, Pedersen UG, Hoste E, Iversen S, Joannidis M, Kellum JA, Liu K, Meersch M, Mehta R, Millington S, Murray PT, Nichol A, Ostermann M, Pettil\u00e4 V, Solling C, Winkel M, Young PJ, Zarbock A (2024) Phase-3 trial of recombinant human alkaline phosphatase for patients with sepsis-associated acute kidney injury (REVIVAL). Intensive Care Med 50:68\u201378. https:\/\/doi.org\/10.1007\/s00134-023-07271-w","journal-title":"Intensive Care Med"},{"key":"8596_CR40","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1056\/nejmoa2102953","volume":"385","author":"LA Inker","year":"2021","unstructured":"Inker LA, Eneanya ND, Coresh J, Tighiouart H, Wang D, Sang Y, Crews DC, Doria A, Estrella MM, Froissart M, Grams ME, Greene T, Grubb A, Gudnason V, Guti\u00e9rrez OM, Kalil R, Karger AB, Mauer M, Navis G, Nelson RG, Poggio ED, Rodby R, Rossing P, Rule AD, Selvin E, Seegmiller JC, Shlipak MG, Torres VE, Yang W, Ballew SH, Couture SJ, Powe NR, Levey AS (2021) New creatinine- and cystatin C-Based equations to estimate GFR without race. N Engl J Med 385:1737\u20131749. https:\/\/doi.org\/10.1056\/nejmoa2102953","journal-title":"N Engl J Med"},{"key":"8596_CR41","doi-asserted-by":"publisher","unstructured":"Mourisse L, Bernard A, Bernholz J, Boehm J, Dubois E, Dumoulin A, Hoste E, Hof L, Hoffmann V, Kraan M, Lemagnen I, Mosbahi S, Ostermann M, Rosenberger P, Schneider A, Thiessen S, Strau\u00df C, Thielmann M, Tuinman PR, Verstraete S, Vandenberghe W, Wirth F, Winkel M, Wenig U, Zarbock A, Vlaar AP, Zarbock A, P P, (13\/05\/2026:101246) Study protocol for a multicentre randomised, double-blinded placebo-controlled phase 2 trial to evaluate safety and efficacy of ilofotase alfa in patients at risk for kidney injury following open heart surgery. JMIR Preprints. https:\/\/doi.org\/10.2196\/preprints.101246","DOI":"10.2196\/preprints.101246"},{"key":"8596_CR42","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s13054-024-04822-5","volume":"28","author":"P Pickkers","year":"2024","unstructured":"Pickkers P, Kraan M, Pardali K, Shaw AD, Shenoi A, Gerss J, Zarbock A (2024) Serum creatinine ratio as predictor of patient-centered long-term outcome after cardiac surgery[Abstract] 43rd International Symposium on Intensive Care & Emergency Medicine. Crit Care 28:68. https:\/\/doi.org\/10.1186\/s13054-024-04822-5","journal-title":"Crit Care"},{"key":"8596_CR43","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1093\/eurheartj\/ehr352","volume":"33","author":"SJ Pocock","year":"2012","unstructured":"Pocock SJ, Ariti CA, Collier TJ, Wang D (2012) The win ratio: a new approach to the analysis of composite endpoints in clinical trials based on clinical priorities. Eur Heart J 33:176\u2013182. https:\/\/doi.org\/10.1093\/eurheartj\/ehr352","journal-title":"Eur Heart J"},{"issue":"10521","key":"8596_CR44","doi-asserted-by":"publisher","first-page":"2782","DOI":"10.1016\/s0140-6736(25)01717-9","volume":"406","author":"A Zarbock","year":"2025","unstructured":"Zarbock A, Ostermann M, Forni L, Bode C, Wild L, Putensen C, Roux DP, Mart\u00edn EE, Arndt C, Rahmel T, de Rosa S, Monard C, Schneider AG, Glass A, Jung-K\u00f6nig M, Romagnoli S, Gossage J, Lumlertgul N, Haaker JG, Ripoll\u00e9s-Melchor J, Spadaro S, Siniscalchi A, Futier E, Aupetitgendre L, Bhathal IR, \u00c1lvarez RG, Bernard A, Rosenberger P, Wempe C, Sadjadi M, Meersch M, Fischhuber K, Bellomo R, Kellum JA, von Groote T, Vandenberghe W, Vanhulle L, Hoste E, Lalande R, Futier E, Schiff U, Aupetitgendre L, Zarbock A, von Groote T, Meersch M, Wempe C, Sadjadi M, Booke H, Weiss R, Strau\u00df C, Meschede D, Fischhuber K, Danzer MF, Ger\u00df J, Haaker JG, G\u00f6bel UM, Brune MJ, Hemping-Bovenkerk A, Brenner T, Espeter F, Berger MM, Rahmel T, Adamzik M, Unterberg M, Marko B, Brandenburger T, Dimski T, Kindgen-Milles D, M\u00f6rer O, Bode C, Wild L, Putensen C, Kruse P, Peukert K, Sauer A, Bernard A, Rosenberger P, H\u00e4berle H, Mirakaj V, Jung-K\u00f6nig M, Larmann J, Weigand MA, H\u00f6lzer HT, Wimmelmeier I, Pielmeier S, Reutershan J, Ellerkmann R, Arndt C, Schubert A-K, Vojnar B, Wulf H, G\u00fcldner A, Mirus M, Spieth PM, Romagnoli S, Villa G, Mura B, Turi L, Siniscalchi A, Tigano S, Capozzi C, Seccafico C, Cattin L, De Cal M, Rojo MS, D\u2019Arcangelo BF, Scaramuzzo G, Volta CA, Hollmann MW, Bauer WO, Breel-Tebbutt JS, Ripoll\u00e9s-Melchor J, Fern\u00e1ndez-Valdes-Bango P, Ruiz-Escobar A, Abad-Gurumeta A, Roux DP, Mart\u00edn EE, De Las Heras BP, G\u00f3mez-Rojo M, Balvis Balvis A, Su\u00e1rez-de-la-Rica A, L\u00f3pez C, Maseda E, Bhathal IR, J\u00e1uregui MP, Rivera-Ramos H, Adr\u00e1n MA, Navarro-Perez R, Embid-Rojas M, Sante-Serna L, Alcantara PV, Su\u00e1rez-de-la-Rica A, \u00c1lvarez RG, S\u00e1nchez EM, Nieto PR, Molinero \u00c1M, Schneider AG, Monard C, Chiche JD, Ahmad Y, Ferlay C, Ostermann M, Sallam M, Lumlertgul N, Haines R, Zaynah N, Gossage J, Marczin N, Verzelloni Sef A, Scaramuzzi M, Glass A, Silversides J, Lonsdale E, Turley-Rock C, Forni L, Haider F, Rossiter A, Bhogal P, Welters ID, Yuan J-X, Shaw D (2025) A preventive care strategy to reduce moderate or severe acute kidney injury after major surgery (BigpAK-2); a multinational, randomised clinical trial. Lancet 406(10521):2782\u20132791. https:\/\/doi.org\/10.1016\/s0140-6736(25)01717-9","journal-title":"Lancet"},{"key":"8596_CR45","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1097\/mcc.0000000000001331","volume":"31","author":"Y Vogelaar","year":"2025","unstructured":"Vogelaar Y, Mourisse L, Pickkers P (2025) The therapeutic horizon of acute kidney injury in critical care: exploring pathology, promises, pitfalls, and progress. Curr Opin Crit Care 31:680\u2013691. https:\/\/doi.org\/10.1097\/mcc.0000000000001331","journal-title":"Curr Opin Crit Care"},{"key":"8596_CR46","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1097\/mcc.0000000000001217","volume":"30","author":"L Mourisse","year":"2024","unstructured":"Mourisse L, Pickkers P (2024) New drugs on the horizon for acute kidney injury. Curr Opin Crit Care 30:577\u2013582. https:\/\/doi.org\/10.1097\/mcc.0000000000001217","journal-title":"Curr Opin Crit Care"},{"key":"8596_CR47","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s00228-008-0591-6","volume":"65","author":"P Pickkers","year":"2009","unstructured":"Pickkers P, Snellen F, Rogiers P, Bakker J, Jorens P, Meulenbelt J, Spapen H, Tulleken JE, Lins R, Ramael S, Bulitta M, van der Hoeven JG (2009) Clinical pharmacology of exogenously administered alkaline phosphatase. Eur J Clin Pharmacol 65:393\u2013402. https:\/\/doi.org\/10.1007\/s00228-008-0591-6","journal-title":"Eur J Clin Pharmacol"},{"key":"8596_CR48","doi-asserted-by":"publisher","first-page":"R14","DOI":"10.1186\/cc11159","volume":"16","author":"P Pickkers","year":"2012","unstructured":"Pickkers P, Heemskerk S, Schouten J, Laterre PF, Vincent JL, Beishuizen A, Jorens PG, Spapen H, Bulitta M, Peters WH, van der Hoeven JG (2012) Alkaline phosphatase for treatment of sepsis-induced acute kidney injury: a prospective randomized double-blind placebo-controlled trial. Crit Care 16:R14. https:\/\/doi.org\/10.1186\/cc11159","journal-title":"Crit Care"},{"key":"8596_CR49","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s13054-024-04837-y","volume":"28","author":"N Bruse","year":"2024","unstructured":"Bruse N, Pardali K, Kraan M, Kox M, Pickkers P (2024) Phenotype-specific therapeutic efficacy of ilofotase alfa in patients with sepsis-associated acute kidney injury. Crit Care 28:50. https:\/\/doi.org\/10.1186\/s13054-024-04837-y","journal-title":"Crit Care"},{"key":"8596_CR50","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1053\/j.ajkd.2013.11.027","volume":"63","author":"E Peters","year":"2014","unstructured":"Peters E, Heemskerk S, Masereeuw R, Pickkers P (2014) Alkaline phosphatase: a possible treatment for sepsis-associated acute kidney injury in critically ill patients. Am J Kidney Dis 63:1038\u20131048. https:\/\/doi.org\/10.1053\/j.ajkd.2013.11.027","journal-title":"Am J Kidney Dis"},{"key":"8596_CR51","doi-asserted-by":"publisher","first-page":"205031212412284","DOI":"10.1177\/20503121241228446","volume":"12","author":"KB Bufkin","year":"2024","unstructured":"Bufkin KB, Karim ZA, Silva J (2024) Review of the limitations of current biomarkers in acute kidney injury clinical practices. SAGE Open Med 12:20503121241228450. https:\/\/doi.org\/10.1177\/20503121241228446","journal-title":"SAGE Open Med"}],"container-title":["Intensive Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-026-08596-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00134-026-08596-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-026-08596-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T11:40:04Z","timestamp":1789990804000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00134-026-08596-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,21]]},"references-count":51,"alternative-id":["8596"],"URL":"https:\/\/doi.org\/10.1007\/s00134-026-08596-y","relation":{},"ISSN":["0342-4642","1432-1238"],"issn-type":[{"value":"0342-4642","type":"print"},{"value":"1432-1238","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,21]]},"assertion":[{"value":"28 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"LM: LM serves as the Medical and Scientific Advisor for this trial. The Intensive Care Research Department at Radboud UMC Nijmegen, the Netherlands, is reimbursed for this role, while LM does not receive any direct financial compensation. MO: MO received research funding from Baxter and Biomerieux which was paid to the institution. ST: no conflict of interest to declare. AD: no conflict of interest to declare. AV: Received consulting fees and grants from Edwards Lifesciences, AM-Pharma and CSL Behring paid to the institution. EH: no conflict of interest to declare. SM: no conflict of interest to declare. AS: no conflict of interest to declare. AZ: AZ has received consulting fees from Astute-Biomerieux, Baxter, Bayer, Novartis, Guard Therapeutics, Dropshot Therapeutics, Chugai, Viatris, AM-Pharma, Paion, Fresenius, research funding from Astute-Biomerieux, Fresenius, Baxter, and speakers\u2019 fees from Astute-Biomerieux, Fresenius, Baxter, JoB: no conflict of interest to declare. PR: no conflict of interest to declare. MT: no conflict of interest to declare. ED: no conflict of interest to declare. JPK: no conflict of interest to declare. KB: no conflict of interest to declare. WR: no conflict of interest to declare. IM: no conflict of interest to declare. MKR: no conflict of interest to declare. KO: no conflict of interest to declare. WV: no conflict of interest to declare. MS: no conflict of interest to declare. CS: no conflict of interest to declare. FW: no conflict of interest to declare. MW: is an employee of AM-Pharma bv. LH: is an employee of AM-Pharma bv. MK: is an employee of AM-Pharma bv. JB: is an employee of AM-Pharma bv. PP: PP received travel and consultancy reimbursements from AM-Pharma. AM-Pharma funded the trial and supplied resources for the conduction of the trial.","order":1,"name":"Ethics","label":"Conflicts of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}